Ecosprin AV 75mg/20mg capsule is used to treat and prevent,

• Angina

• Heart attack

• Stroke

• High cholesterol

The first drug works by inhibiting the activity of an enzyme called cyclooxygenase (COX), specifically COX-1, which is involved in the production of thromboxane A2. Thromboxane A2 promotes platelet aggregation, which can lead to the formation of blood clots. By inhibiting thromboxane A2 production, this drug helps prevent excessive platelet aggregation and reduces the risk of blood clot formation. The other drug works by inhibiting an enzyme called HMG-CoA reductase, which is involved in the production of cholesterol in the liver. By inhibiting this enzyme, this drug reduces the synthesis of cholesterol, leading to a decrease in total cholesterol and low-density lipoprotein (LDL) cholesterol levels.

Inform your healthcare provider about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Ecosprin AV 75mg/20mg capsule and reduce effectiveness by causing undesirable side effects. 

• Store Ecosprin AV 75mg/20mg capsule at room temperature (25°C).
• Keep the capsule out of reach of children and pets.

It is an orally available prescription drug. Your doctor will decide the duration and dose of the drug based on the disease condition and other factors. Always take an Ecosprin AV 75mg/20mg capsule as prescribed by your doctor. Take the capsule with or without food. Do not open, break, chew, or crush the capsule. Swallow the whole capsule with water.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious

• Vomiting with blood
• Blood in your urine
• Bruising with purple spots
• Black stools
• Decreased red blood cell counts
• Kidney stones (which can cause severe stomach or back pains).

Common

• Diarrhea
• Nausea
• Ringing in your ears
• Pain or discomfort in your stomach
• Liver problems with symptoms may include whites of the eyes (jaundice) or yellowing of the skin, dark yellow urine, and fatigue.

Avoid exceeding the recommended dose or frequency of use unless your doctor advises. Before starting Ecosprin AV 75mg/20mg capsule or any medication, inform your healthcare professional about any existing medical conditions, allergies, or medications you are taking for other issues. This detail will help them to decide if this capsule suits them and if any precautions or adjustments are necessary. Take this capsule after consulting your healthcare professional if you feel better. This capsule should be stored in a safe place, out of the reach of children. Accidental ingestion of this drug by children can be harmful.

1. Alliance Pharmaceuticals Limited, Patient information leaflet Aspirin 300mg - medicines (EMC). [Revised on Aug 2022], Available at: https://www.medicines.org.uk/emc/files/pil.8627.pdf (Accessed 29 May 2023).
2. Sun Pharmaceutical Industries Europe B.V, Patient information leaflet, Atorvastatin medicines (EMC). [Revised on April 2022], Available at: https://www.medicines.org.uk/emc/files/pil.4339.pdf (Accessed 29 May 2023).
3. Aspirin- food and drug administration (FDA). [Revised on Sep 2015], Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/200671s000lbl.pdf (Accessed on 29 May 2023).
4. Package leaflet: Information for the user - Aspirin. www.hpra.ie. [Revised on Dec 2019], Available at: https://www.hpra.ie/img/uploaded/swedocuments/697b07a9-17b2-42b9-bdaa-20bc441264e4.pdf (Accessed on 29 May 2023).
5. Package leaflet: Information for the user -Atorvastatin. www.hpra.ie. [Revised on June 2017], Available at: https://www.hpra.ie/img/uploaded/swedocuments/2193794.PPA1562_099_003.60fea6bf-c1d1-4c64-b6fc-d5cbfe4298e2.000001Lipitor%2040mg%20PIL.170726.pdf (Accessed on 29 May 2023).
6. Goodman & Gilman's, The Pharmacological Basis of Therapeutics, Modulation of Cardiovascular function, 12th edition, 2011, 754.
7. KD Tripathi, Essentials of Medical Pharmacology, Autacoids and related drugs, NSAIDs and antipyretic analgesics, 7th edition, 2013, 184,193.